Hyasis increases in vitro drug release to 15 hours
Hyasis, the Bacillus-derived hyaluronic acid from Novozymes Biopharma, helps formulation scientists meet emerging challenges in drug development with controlled and sustained release
2013-07-19 Novozymes Biopharma

Login/Register
Supplier Login












Home








